Nature Communications (Jun 2023)

Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis

  • Irfete S. Fetahu,
  • Wolfgang Esser-Skala,
  • Rohit Dnyansagar,
  • Samuel Sindelar,
  • Fikret Rifatbegovic,
  • Andrea Bileck,
  • Lukas Skos,
  • Eva Bozsaky,
  • Daria Lazic,
  • Lisa Shaw,
  • Marcus Tötzl,
  • Dora Tarlungeanu,
  • Marie Bernkopf,
  • Magdalena Rados,
  • Wolfgang Weninger,
  • Eleni M. Tomazou,
  • Christoph Bock,
  • Christopher Gerner,
  • Ruth Ladenstein,
  • Matthias Farlik,
  • Nikolaus Fortelny,
  • Sabine Taschner-Mandl

DOI
https://doi.org/10.1038/s41467-023-39210-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Metastasis is the major cause of cancer-related deaths. Neuroblastoma (NB), a childhood tumor has been molecularly defined at the primary cancer site, however, the bone marrow (BM) as the metastatic niche of NB is poorly characterized. Here we perform single-cell transcriptomic and epigenomic profiling of BM aspirates from 11 subjects spanning three major NB subtypes and compare these to five age-matched and metastasis-free BM, followed by in-depth single cell analyses of tissue diversity and cell-cell interactions, as well as functional validation. We show that cellular plasticity of NB tumor cells is conserved upon metastasis and tumor cell type composition is NB subtype-dependent. NB cells signal to the BM microenvironment, rewiring via macrophage mgration inhibitory factor and midkine signaling specifically monocytes, which exhibit M1 and M2 features, are marked by activation of pro- and anti-inflammatory programs, and express tumor-promoting factors, reminiscent of tumor-associated macrophages. The interactions and pathways characterized in our study provide the basis for therapeutic approaches that target tumor-to-microenvironment interactions.